Literature DB >> 19052095

Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.

Ursula J Buchholz1, Jerrold M Ward, Elaine W Lamirande, Britta Heinze, Christine D Krempl, Peter L Collins.   

Abstract

Pneumonia virus of mice (PVM) strain 15 causes fatal pneumonia in mice and provides a convenient model for human respiratory syncytial virus pathogenesis and immunobiology. We prepared PVM mutants lacking the genes for nonstructural proteins NS1 and/or NS2. In Vero cells, which lack type I interferon (IFN), deletion of these proteins had no effect on the efficiency of virus growth. In IFN-competent mouse embryo fibroblasts, wild-type (wt) PVM and the DeltaNS1 virus grew efficiently and strongly inhibited the IFN response, whereas virus lacking NS2 was highly attenuated and induced high levels of IFN and IFN-inducible genes. In BALB/c mice, intranasal infection with wt PVM caused overt disease that began on day 6 and was lethal by day 9 postinoculation. In comparison, DeltaNS1 induced transient, reduced disease, and DeltaNS2 and DeltaNS12 caused no disease. Thus, NS1 and NS2 are virulence factors, with NS2 being a major antagonist of the type I IFN system. The pulmonary titers of wt PVM and DeltaNS1 were high on day 3 and increased further by day 6; in addition, expression of IFN and representative proinflammatory cytokines/chemokines and T lymphocyte-related cytokines was undetectable on day 3 but increased dramatically by day 6 coincident with the onset of disease. The titers of DeltaNS2 and DeltaNS12 were somewhat lower on day 3 and decreased further by day 6; in addition, these viruses induced a more circumscribed set of cytokines/chemokines (IFN, interleukin-6 [IL-6], and CXCL10) that were detected on day 3 and had largely subsided by day 6. Lung immunohistology revealed abundant PVM-positive pneumocytes and bronchial and bronchiolar epithelial cells in wt PVM- and DeltaNS1-infected mice on day 6 compared to few PVM-positive foci with DeltaNS2 and DeltaNS12. These results indicate that severe PVM disease is associated with high, poorly controlled virus replication driving the expression of high levels of pulmonary IFN and a broad array of cytokines/chemokines. In contrast, in the absence of NS2, there was an early, transient innate response involving moderate levels of IFN, IL-6, and CXCL10 that restricted virus replication and prevented disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052095      PMCID: PMC2643780          DOI: 10.1128/JVI.02041-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Immunohistochemical markers for the rodent immune system.

Authors:  Jerrold M Ward; Cindy R Erexson; Lawrence J Faucette; Julie F Foley; Christine Dijkstra; Giorgio Cattoretti
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

2.  Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.

Authors:  Joanne Elliott; Oonagh T Lynch; Yvonne Suessmuth; Ping Qian; Caroline R Boyd; James F Burrows; Richard Buick; Nigel J Stevenson; Olivier Touzelet; Massimo Gadina; Ultan F Power; James A Johnston
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

Review 3.  Th17 cells and mucosal host defense.

Authors:  Shean J Aujla; Patricia J Dubin; Jay K Kolls
Journal:  Semin Immunol       Date:  2007-11-28       Impact factor: 11.130

Review 4.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

Review 5.  Viral and host factors in human respiratory syncytial virus pathogenesis.

Authors:  Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

6.  Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery.

Authors:  Harald Petry; Linda Cashion; Paul Szymanski; Oliver Ast; Ann Orme; Cynthia Gross; Maxine Bauzon; Alan Brooks; Caralee Schaefer; Heather Gibson; Husheng Qian; Gabor M Rubanyi; Richard N Harkins
Journal:  J Interferon Cytokine Res       Date:  2006-10       Impact factor: 2.607

7.  Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.

Authors:  Mathias Buttmann; Friederike Berberich-Siebelt; Edgar Serfling; Peter Rieckmann
Journal:  J Vasc Res       Date:  2006-12-13       Impact factor: 1.934

8.  Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses.

Authors:  Yutaro Kumagai; Osamu Takeuchi; Hiroki Kato; Himanshu Kumar; Kosuke Matsui; Eiichi Morii; Katsuyuki Aozasa; Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

9.  Identification of a novel virulence factor in recombinant pneumonia virus of mice.

Authors:  Christine D Krempl; Anna Wnekowicz; Elaine W Lamirande; Giw Nayebagha; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

10.  Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.

Authors:  Kevin B Walsh; Robert A Edwards; Kimberley M Romero; Matthew V Kotlajich; Stephen A Stohlman; Thomas E Lane
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  14 in total

1.  Evaluation of pneumonia virus of mice as a possible human pathogen.

Authors:  Linda G Brock; Ruth A Karron; Christine D Krempl; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

2.  The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Authors:  Jeanette I Webster Marketon; Jacqueline Corry; Michael N Teng
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

3.  Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Authors:  Kevin B Walsh; John R Teijaro; Linda G Brock; Daniel M Fremgen; Peter L Collins; Hugh Rosen; Michael B A Oldstone
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo.

Authors:  Britta Heinze; Stefanie Frey; Markus Mordstein; Anette Schmitt-Gräff; Stephan Ehl; Ursula J Buchholz; Peter L Collins; Peter Staeheli; Christine D Krempl
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

5.  In situ evolution of virus-specific cytotoxic T cell responses in the lung.

Authors:  Stefanie Frey; Hanspeter Pircher; Marie Follo; Peter Collins; Christine Krempl; Stephan Ehl
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

6.  S. mansoni bolsters anti-viral immunity in the murine respiratory tract.

Authors:  Sebastian Scheer; Christine Krempl; Carsten Kallfass; Stefanie Frey; Thilo Jakob; Gabriel Mouahid; Hélène Moné; Annette Schmitt-Gräff; Peter Staeheli; Marinus C Lamers
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

7.  Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

Authors:  Mary J G van Helden; Peter J S van Kooten; Cornelis P J Bekker; Andrea Gröne; David J Topham; Andrew J Easton; Claire J P Boog; Dirk H Busch; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

8.  Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus.

Authors:  Stephanie Glineur; Dao Bui Tran Anh; Michaël Sarlet; Charles Michaux; Daniel Desmecht
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 9.  The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Stephanie Glineur; Joseph B Domachowske; Helene F Rosenberg
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.

Authors:  James T Van Leuven; Andres J Gonzalez; Emmanuel C Ijezie; Alexander Q Wixom; John L Clary; Maricris N Naranjo; Benjamin J Ridenhour; Craig R Miller; Tanya A Miura
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.